Innogen Pharmaceuticals Receives PIC/S GMP Certificatation, Accelerating Global Expansion of Efsubaglutide Alfa

RegulatoryapprovedEfsubaglutide alfaPositive

AI Analysis

Summary

Innogen Pharmaceuticals announced that its Suzhou manufacturing facility for Efsubaglutide alfa has received PIC/S GMP Certification, supporting the global expansion of this metabolic disease treatment.

Outcome Details

PIC/S GMP Certification obtained for Suzhou manufacturing facility

Importance:6/10

Sentiment:

0.70

manufacturingGMP certificationglobal expansionmetabolic diseasesChina

Related Companies

$2591.HK

Read the original article

Published by PR Newswire Pharma on August 4, 2026 5:25 AM

Read Original